Tobam Ascendis Pharma A/S Transaction History

Tobam

$548 Million
Q3 2024

A detailed history of Tobam transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Tobam holds 2,163 shares of ASND stock, worth $294,989. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,163

Previous 2,163 -0.0%

Holding current value

$294,989

Previous $295,000 9.49%

% of portfolio

0.06%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$123.45 - $159.4 $77,773 - $100,422	630 Added 41.1%	2,163 $327,000
Q4 2023 Jan 26, 2024	SELL	$86.1 - $127.36 $23,849 - $35,278	-277 Reduced 15.3%	1,533 $193,000
Q1 2023 May 03, 2023	SELL	$104.9 - $126.78 $75,318 - $91,028	-718 Reduced 28.4%	1,810 $194,000
Q4 2022 Feb 02, 2023	BUY	$99.42 - $131.97 $52,294 - $69,416	526 Added 26.27%	2,528 $309,000
Q3 2022 Nov 02, 2022	BUY	$84.03 - $110.23 $47,392 - $62,169	564 Added 39.22%	2,002 $207,000
Q2 2022 Aug 02, 2022	BUY	$78.08 - $117.61 $95,023 - $143,131	1,217 Added 550.68%	1,438 $134,000
Q1 2022 Apr 25, 2022	SELL	$102.18 - $135.75 $90,224 - $119,867	-883 Reduced 79.98%	221 $26,000
Q4 2021 Feb 15, 2022	SELL	$127.1 - $169.66 $230,813 - $308,102	-1,816 Reduced 62.19%	1,104 $149,000
Q3 2021 Nov 12, 2021	SELL	$112.67 - $176.92 $129,457 - $203,281	-1,149 Reduced 28.24%	2,920 $465,000
Q2 2021 Aug 11, 2021	BUY	$121.62 - $145.29 $110,309 - $131,778	907 Added 28.68%	4,069 $535,000
Q1 2021 May 11, 2021	BUY	$124.92 - $173.33 $103,433 - $143,517	828 Added 35.48%	3,162 $408,000
Q4 2020 Feb 03, 2021	SELL	$151.2 - $182.76 $17,690 - $21,382	-117 Reduced 4.77%	2,334 $389,000
Q3 2020 Nov 12, 2020	BUY	$134.29 - $154.32 $27,126 - $31,172	202 Added 8.98%	2,451 $378,000
Q2 2020 Aug 17, 2020	BUY	$110.87 - $156.01 $61,865 - $87,053	558 Added 33.0%	2,249 $333,000
Q1 2020 May 07, 2020	SELL	$97.01 - $145.11 $9,312 - $13,930	-96 Reduced 5.37%	1,691 $190,000
Q4 2019 Feb 10, 2020	SELL	$91.45 - $139.12 $2,103 - $3,199	-23 Reduced 1.27%	1,787 $249,000
Q3 2019 Nov 12, 2019	BUY	$95.8 - $118.9 $42,726 - $53,029	446 Added 32.7%	1,810 $174,000
Q2 2019 Aug 13, 2019	BUY	$107.11 - $132.09 $146,098 - $180,170	1,364 New	1,364 $157,000

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Account